Literature DB >> 10424683

Glial cell line derived neurotrophic factor (GDNF) regulates VR1 and substance P in cultured sensory neurons.

P Ogun-Muyiwa1, R Helliwell, P McIntyre, J Winter.   

Abstract

Many nociceptive dorsal root ganglion (DRG) sensory neurons express the high affinity nerve growth factor (NGF) receptor TRKA, and respond to NGF. However, many do not express TRKA but are thought to respond to glial cell-derived neurotrophic factor (GDNF) and related molecules. We therefore cultured DRG neurons in the presence of GDNF, and looked at the expression of substance P and of the capsaicin receptor, VR1, two nociceptive properties already known to be NGF regulated. Using several different approaches we demonstrated that GDNF produced clear increases in expression of both properties, comparable in magnitude to increases seen with NGF. Following axotomy, aberrant expression of substance P in A fibres may be involved in the generation of neuropathic pain. Factors regulating substance P and other properties in the absence of retrogradely transported NGF may therefore be of significance in neuropathic pain states.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424683     DOI: 10.1097/00001756-199907130-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Sensitisation of gastrointestinal tract afferents.

Authors:  S B McMahon
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

2.  Augmentation of the ascending component of the peristaltic reflex and substance P release by glial cell line-derived neurotrophic factor.

Authors:  J R Grider; R O Heuckeroth; J F Kuemmerle; K S Murthy
Journal:  Neurogastroenterol Motil       Date:  2010-03-19       Impact factor: 3.598

Review 3.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

4.  Nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) regulate substance P release in adult spinal sensory neurons.

Authors:  Anne M Skoff; Corrine Resta; Muthulekha Swamydas; Joshua E Adler
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

Review 5.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 6.  Contribution of the spared primary afferent neurons to the pathomechanisms of neuropathic pain.

Authors:  Tetsuo Fukuoka; Koichi Noguchi
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

7.  Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibers innervating cochlear and vertebro-basilar arteries.

Authors:  Z Vass; C F Dai; P S Steyger; G Jancsó; D R Trune; A L Nuttall
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  No overlap of sensitivity to capsaicin and expression of galanin in rat dorsal root ganglion neurons after axotomy.

Authors:  Jens R Wendland; Klaus H Schmidt; Martin Koltzenburg; Marlen Petersen
Journal:  Exp Brain Res       Date:  2003-08-29       Impact factor: 1.972

9.  Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.

Authors:  Theodore J Price; Michael D Louria; Damaries Candelario-Soto; Gregory O Dussor; Nathanial A Jeske; Amol M Patwardhan; Anibal Diogenes; Amanda A Trott; Kenneth M Hargreaves; Christopher M Flores
Journal:  BMC Neurosci       Date:  2005-01-24       Impact factor: 3.288

10.  Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.

Authors:  Paul Facer; Maria A Casula; Graham D Smith; Christopher D Benham; Iain P Chessell; Chas Bountra; Marco Sinisi; Rolfe Birch; Praveen Anand
Journal:  BMC Neurol       Date:  2007-05-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.